ENO1 as an autoantigen has been reported in systemic sclerosis (SSc)-associated interstitial lung disease [42] and liver fibrosis [43] evidenced as the frequent presence of anti-ENO1 autoantibodies in these patients. This evidence concerns the gene ENO1 and systemic sclerosis.